Canaccord Genuity Maintains Buy Rating for Exact Sciences: Here's What You Need To Know
Canaccord Genuity has decided to maintain its Buy rating of Exact Sciences (NASDAQ:EXAS) and raise its price target from $92.00 to $115.00. Shares...
Stay updated with breaking news from Base Genomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Canaccord Genuity has decided to maintain its Buy rating of Exact Sciences (NASDAQ:EXAS) and raise its price target from $92.00 to $115.00. Shares...
Liquid biopsies could usher in a paradigm shift in cancer detection and grow exponentially.
Liquid biopsies could usher in a paradigm shift in cancer detection and grow exponentially.
Growing Funding for Genomics and Proteomics Research Likely to Gain Traction in Protein Expression Market During 2021–2028
/PRNewswire/ -- The "Epigenetics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. The global epigenetics market is...